Veminsyn is an innovative startup that offers chemical production services for low-carbon biomanufacturing. The company's bioactive materials cater to the beauty and personal care industry with the aim of expanding to diverse downstream products. Founded in 2021, Veminsyn operates in the industries of Biopharma, Biotechnology, and Manufacturing.
The latest development for Veminsyn is the Series A investment of CNY100.00M, which took place on 24 October 2022. The investment was backed by notable investors including CITIC Capital, ZhenFund, Hony Capital, and Next Capital 嘉程资本.
This funding not only reaffirms the potential of Veminsyn but also signifies a growing interest in sustainable and innovative chemical production. The company's dedication to environmental sustainability and diverse applications positions it as a promising player in the biomanufacturing landscape.
